33.85MMarket Cap-0.47P/E (TTM)
0.592High0.540Low85.19KVolume0.580Open0.560Pre Close47.58KTurnover0.18%Turnover RatioLossP/E (Static)61.77MShares1.79052wk High0.47P/B26.45MFloat Cap0.45152wk Low--Dividend TTM48.26MShs Float38.230Historical High--Div YieldTTM9.23%Amplitude0.451Historical Low0.558Avg Price1Lot Size
Passage Bio Stock Forum
Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates
Friday, 10th January at 7:00 am
PBFT02 demonstrated durable, elevated CSF PGRN levels and early evidence of reduction in plasma NfL levels, a disease progression biomarker, compared to published natural history data
Evaluating Dose 2, 50% lower than Dose 1, in subsequent FTD-GRN and FTD-C9orf72 patients to allow for dose exploration and support regulatory strategy
Expect to ...
NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 CH (cash on hand); AH (after hours): RTH (regular trading hours)
7. Remember, some stocks may get pumped WITHOUT any catalyst
8. It’s 2025, those newbies need to read and educate themselves on stocks. ...
No comment yet